The drug has been in short supply since at least August, an issue that
Teva spokesperson Kelley Dougherty said the company continues to experience intermittent delays in Adderall production and is “producing and distributing ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.